THE PART TRIAL - A PHASE III STUDY COMPARING PARTIAL PROSTATE ABLATION VERSUS RADICAL PROSTATECTOMY (PART) IN INTERMEDIATE RISK PROSTATE CANCER - EARLY DATA FROM THE FEASIBILITY STUDY

被引：2
|
作者：
Leslie, Tom
Davies, Lucy
Elliott, Daisy
Brewster, Simon
Sooriakumaran, Prasanna
Rosario, Derek
Catto, Jim
Dudderidge, Tim
Ahmed, Hashim
Emberton, Mark
Hindley, Richard
Donovan, Jenny
Gray, Richard
Hamdy, Freddie
机构：
来源：
JOURNAL OF UROLOGY | 2017年 / 197卷 / 04期
关键词：
D O I：
10.1016/j.juro.2017.02.2597
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD56-08
引用
收藏
页码：E1118 / E1119
页数：2
相关论文
共 50 条
  • [41] Phase II randomised control feasibility trial of a nutrition and physical activity intervention after radical prostatectomy for prostate cancer
    Hackshaw-McGeagh, Lucy E.
    Penfold, Chris
    Shingler, Ellie
    Robles, Luke A.
    Perks, Claire M.
    Holly, Jeff M. P.
    Rowe, Edward
    Koupparis, Anthony
    Bahl, Amit
    Persad, Raj
    Shiridzinomwa, Constance
    Johnson, Lyndsey
    Biernacka, Kalina M.
    Frankow, Aleksandra
    Woodside, Jayne V.
    Gilchrist, Sarah
    Oxley, Jon
    Abrams, Paul
    Lane, J. Athene
    Martin, Richard M.
    BMJ OPEN, 2019, 9 (11):
  • [42] Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer
    Lantz, Anna
    Nordlund, Per
    Falagario, Ugo
    Joderling, Fredrik
    Ozbek, Orhan
    Clements, Mark
    Discacciati, Andrea
    Gronberg, Henrik
    Eklund, Martin
    Stricker, Phillip
    Emberton, Mark
    Aly, Markus
    Nordstrom, Tobias
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 51 : 89 - 94
  • [43] Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: Results of a phase I/II study
    Konety, BR
    Eastham, JA
    Reuter, VE
    Scardino, PT
    Donat, SM
    Dalbagni, G
    Russo, P
    Herr, HW
    Schwartz, L
    Kantoff, PW
    Scher, H
    Kelly, WK
    JOURNAL OF UROLOGY, 2004, 171 (02): : 709 - 713
  • [44] Re: Risk of Death From Prostate Cancer After Radical Prostatectomy or Brachytherapy in Men With Low or Intermediate Risk Disease
    Trock, Bruce J.
    JOURNAL OF UROLOGY, 2012, 187 (01): : 356 - 356
  • [45] Biochemical Failure in Intermediate Risk Prostate Cancer: Then What? Long -Term Data from a Phase Ill Trial
    Nabid, A.
    Carrier, N.
    Vigneault, E.
    Nguyen, T. V.
    Vavassis, P.
    Brassard, M. A.
    Bahoric, B.
    Archambault, R.
    Vincent, F.
    Bettahar, R.
    Wilke, D. R.
    Souhami, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E421 - E421
  • [46] Multicenter, randomized, phase III trial comparing radical retropubic prostatectomy with conventional external beam radiotherapy for localized prostate cancer: An interim report.
    Di Stasi, S. M.
    Giannantoni, A.
    Valenti, M.
    Storti, L.
    Attisani, F.
    Palloni, T.
    Jannini, E. A.
    Bibas, M.
    Zampa, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 243S - 243S
  • [47] NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer
    Lui Shiong Lee
    Adelene Y. L. Sim
    Chee Wee Ong
    Xinyan Yang
    Cedric C. Y. Ng
    Wei Liu
    Vikneswari Rajasegaran
    Abner M. S. Lim
    Edwin Jonathan Aslim
    Nye-Thane Ngo
    Li-Yan Khor
    Ravindran Kanesvaran
    John Carson Jr Allen
    Kae Jack Tay
    John Shyi Peng Yuen
    Tsung Wen Chong
    Sun Sien Henry Ho
    Bin Tean Teh
    Melvin L. K. Chua
    Prostate Cancer and Prostatic Diseases, 2022, 25 : 741 - 748
  • [48] Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial
    Nabid, Abdenour
    Carrier, Nathalie
    Vigneault, Eric
    Thu Van Nguyen
    Vavassis, Peter
    Brassard, Marc-Andre
    Bahoric, Boris
    Archambault, Robert
    Vincent, Francois
    Bettahar, Redouane
    Wilke, Derek
    Souhami, Luis
    EUROPEAN JOURNAL OF CANCER, 2021, 143 : 64 - 74
  • [49] Re: Androgen deprivation therapy and radiotherapy in intermediate risk prostate cancer: A randomized phase III trial
    Guler, Ozan Cem
    Onal, Cem
    EUROPEAN JOURNAL OF CANCER, 2022, 167 : 164 - 165
  • [50] PHASE 2 TRIAL OF NEOADJUVANT LHRH PLUS ESTRAMUSTINE FOR HIGH RISK PROSTATE CANCER FOLLOWED BY RADICAL PROSTATECTOMY
    Koie, Takuya
    Okamoto, Teppei
    Imanishi, Kengo
    Sugiyama, Naoki
    Suzuki, Yuichiro
    Mori, Kazuyuki
    Kudoh, Shigemasa
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Kamimura, Noritaka
    Ohyama, Chikara
    JOURNAL OF UROLOGY, 2010, 183 (04): : E258 - E258
12345